Endogenous erythropoietin has immunoregulatory functions that limit the expression of autoimmune kidney disease in mice
Frontiers in immunology(2023)
Abstract
BackgroundAdministration of recombinant erythropoietin (EPO), a kidney-produced hormone with erythropoietic functions, has been shown to have multiple immunoregulatory effects in mice and humans, but whether physiological levels of EPO regulate immune function in vivo has not been previously evaluated. MethodsWe generated mice in which we could downregulate EPO production using a doxycycline (DOX)-inducible, EPO-specific silencing RNA (shEPOrtTA(POS)), and we crossed them with B6.MRL-Fas(lpr)/J mice that develop spontaneous lupus. We treated these B6.MRL/lpr shEPOrtTA(POS) with DOX and serially measured anti-dsDNA antibodies, analyzed immune subsets by flow cytometry, and evaluated clinical signs of disease activity over 6 months of age in B6.MRL/lpr shEPOrtTA(POS) and in congenic shEPOrtTA(NEG) controls. ResultsIn B6.MRL/lpr mice, Epo downregulation augmented anti-dsDNA autoantibody levels and increased disease severity and percentages of germinal center B cells compared with controls. It also increased intracellular levels of IL-6 and MCP-1 in macrophages. DiscussionOur data in a murine model of lupus document that endogenous EPO reduces T- and B-cell activation and autoantibody production, supporting the conclusion that EPO physiologically acts as a counterregulatory mechanism to control immune homeostasis.
MoreTranslated text
Key words
germinal center B cell,TFH,TfR,systemic lupus erythematosus,erythropoietin
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined